The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy

  • Charlotte Falke
  • , Fatma Karapinar
  • , Marcel Bouvy
  • , Mariëlle Emmelot
  • , Svetlana Belitser
  • , Benoit Boland
  • , Denis O’Mahony
  • , Kevin D. Murphy
  • , Moa Haller
  • , Paola Salari
  • , Matthias Schwenkglenks
  • , Nicolas Rodondi
  • , Toine Egberts
  • , Wilma Knol

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To explore the association between medication use-related factors and quality of life in older hospitalised patients with polypharmacy. Findings: Hyperpolypharmacy, a high anticholinergic and sedative burden, presence of multiple prescribing omissions (based on START criteria), the use of opioids, antibiotics and benzodiazepines, and high medication complexity were associated with a lower quality of life. Message: Due to the association with quality of life, evaluating medication use-related factors, especially medication complexity as a novel factor, is important for hospitalised older patients with (hyper)polypharmacy.

Original languageEnglish
Pages (from-to)1713-1723
Number of pages11
JournalEuropean Geriatric Medicine
Volume15
Issue number6
DOIs
Publication statusPublished - Dec 2024

Keywords

  • HRQoL
  • Medication complexity
  • Medication use
  • Polypharmacy
  • Quality of life

Fingerprint

Dive into the research topics of 'The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy'. Together they form a unique fingerprint.

Cite this